XML 35 R9.htm IDEA: XBRL DOCUMENT

Selected Balance Sheet Information

12 Months Ended

Dec. 31, 2023

Selected Balance Sheet Information [Abstract]

3.	Selected balance sheet information

Inventory consists of the following at:


	December 31,		December 31,
(in thousands)	2023		2022
Raw material	$	4,714	$	2,390
Work-in-process		654		1,033
Finished goods		5,615		3,534
	$	10,983	$	6,957

Property and equipment, net consists of the following at:


	December 31,		December 31,
(in thousands)	2023		2022
Office furniture and equipment	$	402	$	350
Lab equipment		2,721		2,684
Computer equipment and software		776		618
Leasehold improvements		98		95
Capital equipment in process		554		231
		4,551		3,978
Less: Accumulated depreciation and amortization		2,788		2,280
	$	1,763	$	1,698

Depreciation is determined using the straight-line method over the estimated useful lives of the respective assets, generally three to five years. Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the term of the lease. Depreciation expense was $0.5 million and $0.4 million for the years ended December 31, 2023 and 2022, respectively.

Accrued expenses consist of the following at:


	December 31,		December 31,
(in thousands)	2023		2022
Clinical trial and other professional fees	$	277	$	1,733
Bonuses		3,335		2,303
Paid time off		770		960
Customer rebates		411		256
Operating lease liability, current portion		231		222
Taxes		125		120
Other		831		775
	$	5,980	$	6,369